Evaluation of analytical methods for connectivity map data

Pacific Symposium on Biocomputing

Volumn , Issue , 2013, Pages 5-16

  Cheng, Jie ^a   Xie, Qing ^a   Kumar, Vinod ^a   Hurle, Mark ^a   Freudenberg, Johannes M ^a   Yang, Lun ^a   Agarwal, Pankaj ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIRDS; DRUG THERAPY; GENE THERAPY; PROBES;

AREA UNDER THE CURVE (AUC); GENE EXPRESSION PROFILES; KOLMOGOROV-SMIRNOV; MECHANISM OF ACTION; PREDICTION ACCURACY; RECEIVER OPERATING CHARACTERISTIC (ROC) CURVES; SYSTEMATIC EVALUATION; TRANSCRIPTIONAL RESPONSE;

GENE EXPRESSION;

DRUG; TRANSCRIPTOME;

AREA UNDER THE CURVE; BIOLOGY; CLASSIFICATION; DRUG EFFECTS; DRUG THERAPY; EVALUATION STUDY; GENETIC DATABASE; HUMAN; PHARMACOLOGY; STATISTICAL ANALYSIS; STATISTICS AND NUMERICAL DATA; ARTICLE; DRUG EFFECT; STATISTICS;

AREA UNDER CURVE; COMPUTATIONAL BIOLOGY; DATA INTERPRETATION, STATISTICAL; DATABASES, GENETIC; DRUG THERAPY; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOLOGICAL PHENOMENA; TRANSCRIPTOME;

EID: 84875475890     PISSN: 23356928     EISSN: 23356936     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. J. T. Dudley, T. Deshpande, and A. J. Butte, "Exploiting drug-disease relationships for computational drug repositioning," Brief. Bioinform. 12, 303-311 (2011).
2. J. Lamb, E. D. Crawford, D. Peck, J. W. Modell, I. C. Blat, M. J. Wrobel, J. Lerner, J. P. Brunet, A. Subramanian, K. N. Ross, M. Reich, H. Hieronymus, G. Wei, S. A. Armstrong, S. J. Haggarty, P. A. Clemons, R. Wei, S. A. Carr, E. S. Lander, and T. R. Golub, "The Connectivity Map: using geneexpression signatures to connect small molecules, genes, and disease," Science 313, 1929-1935 (2006).
3. X.A. Qu and Rajpal D.K. Applications of Connectivity Map in Drug Discovery and Development. Drug Discov Today. 2012.
4. M. Chang, S. Smith, A. Thorpe, M. J. Barratt, and F. Karim, "Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping," Mol. Pain 6, 56 (2010).
5. S. Claerhout, J. Y. Lim, W. Choi, Y. Y. Park, K. Kim, S. B. Kim, J. S. Lee, G. B. Mills, and J. Y. Cho, "Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer," PLoS. One. 6, e24662 (2011).
6. J. T. Dudley, M. Sirota, M. Shenoy, R. K. Pai, S. Roedder, A. P. Chiang, A. A. Morgan, M. M. Sarwal, P. J. Pasricha, and A. J. Butte, "Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease," Sci. Transl. Med. 3, 96ra76 (2011).
7. Y. Ishimatsu-Tsuji, T. Soma, and J. Kishimoto, "Identification of novel hair-growth inducers by means of connectivity mapping," FASEB J. 24, 1489-1496 (2010).
8. S. D. Kunkel, M. Suneja, S. M. Ebert, K. S. Bongers, D. K. Fox, S. E. Malmberg, F. Alipour, R. K. Shields, and C. M. Adams, "mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass," Cell Metab 13, 627-638 (2011).
9. T. Barrett, D. B. Troup, S. E. Wilhite, P. Ledoux, C. Evangelista, I. F. Kim, M. Tomashevsky, K. A. Marshall, K. H. Phillippy, P. M. Sherman, R. N. Muertter, M. Holko, O. Ayanbule, A. Yefanov, and A. Soboleva, "NCBI GEO: archive for functional genomics data sets-10 years on," Nucleic Acids Res. 39, D1005-D1010 (2011).
10. M. Iskar, M. Campillos, M. Kuhn, L. J. Jensen, V. van Noort, and P. Bork, "Drug-induced regulation of target expression," PLoS. Comput. Biol. 6, (2010).
11. F. Iorio, R. Bosotti, E. Scacheri, V. Belcastro, P. Mithbaokar, R. Ferriero, L. Murino, R. Tagliaferri, N. Brunetti-Pierri, A. Isacchi, and D. di Bernardo, "Discovery of drug mode of action and drug repositioning from transcriptional responses," Proc. Natl. Acad. Sci. U. S. A 107, 14621-14626 (2010).
12. J. D. Tenenbaum, M. G. Walker, P. J. Utz, and A. J. Butte, "Expression-based Pathway Signature Analysis (EPSA): mining publicly available microarray data for insight into human disease," BMC. Med. Genomics 1, 51 (2008).
13. Y. Yi, C. Li, C. Miller, and A. L. George, Jr., "Strategy for encoding and comparison of gene expression signatures," Genome Biol. 8, R133 (2007).
14. A. C. Gower, A. Spira, and M. E. Lenburg, "Discovering biological connections between experimental conditions based on common patterns of differential gene expression," BMC. Bioinformatics. 12, 381 (2011).
15. J. M. Engreitz, R. Chen, A. A. Morgan, J. T. Dudley, R. Mallelwar, and A. J. Butte, "ProfileChaser: searching microarray repositories based on genome-wide patterns of differential expression," Bioinformatics. 27, 3317-3318 (2011).
16. M. A. Sartor, G. D. Leikauf, and M. Medvedovic, "LRpath: a logistic regression approach for identifying enriched biological groups in gene expression data," Bioinformatics. 25, 211-217 (2009).
17. R. Z. Vencio and I. Shmulevich, "ProbCD: enrichment analysis accounting for categorization uncertainty," BMC. Bioinformatics. 8, 383 (2007).
18. S. W. Tanner and P. Agarwal, "Gene Vector Analysis (Geneva): a unified method to detect differentially-regulated gene sets and similar microarray experiments," BMC. Bioinformatics. 9, 348 (2008).
19. J. M. Freudenberg, S. Sivaganesan, M. Phatak, K. Shinde, and M. Medvedovic, "Generalized random set framework for functional enrichment analysis using primary genomics datasets," Bioinformatics. 27, 70-77 (2011).
20. M. R. Segal, H. Xiong, H. Bengtsson, R. Bourgon, and R. Gentleman, "Querying genomic databases: refining the connectivity map," Stat. Appl. Genet. Mol. Biol. 11, (2012).
21. R. A. Irizarry, B. Hobbs, F. Collin, Y. D. Beazer-Barclay, K. J. Antonellis, U. Scherf, and T. P. Speed, "Exploration, normalization, and summaries of high density oligonucleotide array probe level data," Biostatistics. 4, 249-264 (2003).
22. A. Ben-Hur and I. Guyon, "Detecting stable clusters using principal component analysis," Methods Mol. Biol. 224, 159-182 (2003).
23. X. Robin, N. Turck, A. Hainard, N. Tiberti, F. Lisacek, J. C. Sanchez, and M. Muller, "pROC: an open-source package for R and S+ to analyze and compare ROC curves," BMC. Bioinformatics. 12, 77 (2011).
24. D. Shigemizu, Z. Hu, J. H. Hung, C. L. Huang, Y. Wang, and C. DeLisi, "Using functional signatures to identify repositioned drugs for breast, myelogenous leukemia and prostate cancer," PLoS. Comput. Biol. 8, e1002347 (2012).